SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-004129
Filing Date
2021-11-10
Accepted
2021-11-10 16:37:58
Documents
63
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q inab-20210930.htm   iXBRL 10-Q 2167224
2 EX-31.1 inab-ex31_1.htm EX-31.1 21264
3 EX-31.2 inab-ex31_2.htm EX-31.2 21169
4 EX-32.1 inab-ex32_1.htm EX-32.1 20796
5 GRAPHIC img237019786_0.jpg GRAPHIC 54108
  Complete submission text file 0000950170-21-004129.txt   7000729

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT inab-20210930_def.xml EX-101.DEF 132675
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT inab-20210930_pre.xml EX-101.PRE 285902
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT inab-20210930_cal.xml EX-101.CAL 44027
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT inab-20210930_lab.xml EX-101.LAB 392323
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT inab-20210930.xsd EX-101.SCH 43678
11 EXTRACTED XBRL INSTANCE DOCUMENT inab-20210930_htm.xml XML 1028328
Mailing Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118
Business Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118 (646) 600-6438
IN8BIO, INC. (Filer) CIK: 0001740279 (see all company filings)

IRS No.: 825462585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39692 | Film No.: 211397306
SIC: 2836 Biological Products, (No Diagnostic Substances)